 | • レポートコード：D0GIR-00191 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、120ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、抗ウイルス経口液の世界市場を広く調査・分析し、今後の市場展望をまとめております。抗ウイルス経口液の種類別市場規模（シロップ、経口懸濁液、経口液剤、経口滴下剤、経口乳液、混合物）、用途別市場規模（大人、子供）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Pfizer、Sanofi、Merck、Roche、AbbVie、Novartis、AstraZeneca、Johnson & Johnson、GlaxoSmithKline、Bristol-Myers Squibb、CSL、Celgene、Eli Lilly、Allergan、Takeda Pharmaceuticals、Gilead Sciences、Novo Nordisk、Merck KGaA、Bayer、Amgen ・地域別グローバル市場分析 2015年-2020年 ・抗ウイルス経口液の北米市場（アメリカ、カナダ、メキシコ） ・抗ウイルス経口液のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・抗ウイルス経口液のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・抗ウイルス経口液の南米市場（ブラジル、アルゼンチン） ・抗ウイルス経口液の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：シロップ、経口懸濁液、経口液剤、経口滴下剤、経口乳液、混合物 ・用途別分析：大人、子供 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Antiviral Oral Liquid market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Antiviral Oral Liquid sales will be xx in 2020 from Antiviral Oral Liquid million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Antiviral Oral Liquid market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Antiviral Oral Liquid industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Antiviral Oral Liquid and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Antiviral Oral Liquid market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Antiviral Oral Liquid market has been segmented into:
Syrup
Oral suspension
Oral solution
Oral drop
Oral emulsion
Mixture
By Application, Antiviral Oral Liquid has been segmented into:
Adults
Children
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Antiviral Oral Liquid market presented in the report. This section sheds light on the sales growth of different regional and country-level Antiviral Oral Liquid markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Antiviral Oral Liquid market.
The report offers in-depth assessment of the growth and other aspects of the Antiviral Oral Liquid market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Antiviral Oral Liquid Market Share Analysis
Antiviral Oral Liquid competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Antiviral Oral Liquid sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Antiviral Oral Liquid sales, revenue and market share for each player covered in this report.
The major players covered in Antiviral Oral Liquid are:
Pfizer
Sanofi
Merck
Roche
AbbVie
Novartis
AstraZeneca
Johnson & Johnson
GlaxoSmithKline
Bristol-Myers Squibb
CSL
Celgene
Eli Lilly
Allergan
Takeda Pharmaceuticals
Gilead Sciences
Novo Nordisk
Merck KGaA
Bayer
Amgen
Among other players domestic and global, Antiviral Oral Liquid market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Antiviral Oral Liquid Market Overview
1.1 Product Overview and Scope of Antiviral Oral Liquid
1.2 Classification of Antiviral Oral Liquid by Type
1.2.1 Global Antiviral Oral Liquid Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Antiviral Oral Liquid Revenue Market Share by Type in 2019
1.2.3 Syrup
1.2.4 Oral suspension
1.2.5 Oral solution
1.2.6 Oral drop
1.2.7 Oral emulsion
1.2.8 Mixture
1.3 Global Antiviral Oral Liquid Market by Application
1.3.1 Overview: Global Antiviral Oral Liquid Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Adults
1.3.3 Children
1.4 Global Antiviral Oral Liquid Market by Regions
1.4.1 Global Antiviral Oral Liquid Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Antiviral Oral Liquid (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Antiviral Oral Liquid Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Antiviral Oral Liquid Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Antiviral Oral Liquid Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Antiviral Oral Liquid Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Antiviral Oral Liquid Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Antiviral Oral Liquid Industry Impact
1.5.1 COVID-19 Potential Implications for the Antiviral Oral Liquid
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Antiviral Oral Liquid
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Antiviral Oral Liquid Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Sanofi SWOT Analysis
2.2.4 Sanofi Product and Services
2.2.5 Sanofi Antiviral Oral Liquid Revenue, Gross Margin and Market Share (2018-2019)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Merck SWOT Analysis
2.3.4 Merck Product and Services
2.3.5 Merck Antiviral Oral Liquid Revenue, Gross Margin and Market Share (2018-2019)
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Roche SWOT Analysis
2.4.4 Roche Product and Services
2.4.5 Roche Antiviral Oral Liquid Revenue, Gross Margin and Market Share (2018-2019)
2.5 AbbVie
2.5.1 AbbVie Details
2.5.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 AbbVie SWOT Analysis
2.5.4 AbbVie Product and Services
2.5.5 AbbVie Antiviral Oral Liquid Revenue, Gross Margin and Market Share (2018-2019)
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Novartis Product and Services
2.6.4 Novartis Antiviral Oral Liquid Revenue, Gross Margin and Market Share (2018-2019)
2.7 AstraZeneca
2.7.1 AstraZeneca Details
2.7.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 AstraZeneca Product and Services
2.7.4 AstraZeneca Antiviral Oral Liquid Revenue, Gross Margin and Market Share (2018-2019)
2.8 Johnson & Johnson
2.8.1 Johnson & Johnson Details
2.8.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Johnson & Johnson Product and Services
2.8.4 Johnson & Johnson Antiviral Oral Liquid Revenue, Gross Margin and Market Share (2018-2019)
2.9 GlaxoSmithKline
2.9.1 GlaxoSmithKline Details
2.9.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 GlaxoSmithKline Product and Services
2.9.4 GlaxoSmithKline Antiviral Oral Liquid Revenue, Gross Margin and Market Share (2018-2019)
2.10 Bristol-Myers Squibb
2.10.1 Bristol-Myers Squibb Details
2.10.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Bristol-Myers Squibb Product and Services
2.10.4 Bristol-Myers Squibb Antiviral Oral Liquid Revenue, Gross Margin and Market Share (2018-2019)
2.11 CSL
2.11.1 CSL Details
2.11.2 CSL Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 CSL Product and Services
2.11.4 CSL Antiviral Oral Liquid Revenue, Gross Margin and Market Share (2018-2019)
2.12 Celgene
2.12.1 Celgene Details
2.12.2 Celgene Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Celgene Product and Services
2.12.4 Celgene Antiviral Oral Liquid Revenue, Gross Margin and Market Share (2018-2019)
2.13 Eli Lilly
2.13.1 Eli Lilly Details
2.13.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Eli Lilly Product and Services
2.13.4 Eli Lilly Antiviral Oral Liquid Revenue, Gross Margin and Market Share (2018-2019)
2.14 Allergan
2.14.1 Allergan Details
2.14.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Allergan Product and Services
2.14.4 Allergan Antiviral Oral Liquid Revenue, Gross Margin and Market Share (2018-2019)
2.15 Takeda Pharmaceuticals
2.15.1 Takeda Pharmaceuticals Details
2.15.2 Takeda Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Takeda Pharmaceuticals Product and Services
2.15.4 Takeda Pharmaceuticals Antiviral Oral Liquid Revenue, Gross Margin and Market Share (2018-2019)
2.16 Gilead Sciences
2.16.1 Gilead Sciences Details
2.16.2 Gilead Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Gilead Sciences Product and Services
2.16.4 Gilead Sciences Antiviral Oral Liquid Revenue, Gross Margin and Market Share (2018-2019)
2.17 Novo Nordisk
2.17.1 Novo Nordisk Details
2.17.2 Novo Nordisk Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Novo Nordisk Product and Services
2.17.4 Novo Nordisk Antiviral Oral Liquid Revenue, Gross Margin and Market Share (2018-2019)
2.18 Merck KGaA
2.18.1 Merck KGaA Details
2.18.2 Merck KGaA Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Merck KGaA Product and Services
2.18.3 Merck KGaA Antiviral Oral Liquid Revenue, Gross Margin and Market Share (2018-2019)
2.19 Bayer
2.19.1 Bayer Details
2.19.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Bayer Product and Services
2.19.4 Bayer Antiviral Oral Liquid Revenue, Gross Margin and Market Share (2018-2019)
2.20 Amgen
2.20.1 Amgen Details
2.20.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 Amgen Product and Services
2.20.4 Amgen Antiviral Oral Liquid Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Antiviral Oral Liquid Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Antiviral Oral Liquid Players Market Share
3.2.2 Top 10 Antiviral Oral Liquid Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Antiviral Oral Liquid Revenue and Market Share by Regions
4.2 North America Antiviral Oral Liquid Revenue and Growth Rate (2015-2020)
4.3 Europe Antiviral Oral Liquid Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Antiviral Oral Liquid Revenue and Growth Rate (2015-2020)
4.5 South America Antiviral Oral Liquid Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Antiviral Oral Liquid Revenue and Growth Rate (2015-2020)
5 North America Antiviral Oral Liquid Revenue by Countries
5.1 North America Antiviral Oral Liquid Revenue by Countries (2015-2020)
5.2 USA Antiviral Oral Liquid Revenue and Growth Rate (2015-2020)
5.3 Canada Antiviral Oral Liquid Revenue and Growth Rate (2015-2020)
5.4 Mexico Antiviral Oral Liquid Revenue and Growth Rate (2015-2020)
6 Europe Antiviral Oral Liquid Revenue by Countries
6.1 Europe Antiviral Oral Liquid Revenue by Countries (2015-2020)
6.2 Germany Antiviral Oral Liquid Revenue and Growth Rate (2015-2020)
6.3 UK Antiviral Oral Liquid Revenue and Growth Rate (2015-2020)
6.4 France Antiviral Oral Liquid Revenue and Growth Rate (2015-2020)
6.5 Russia Antiviral Oral Liquid Revenue and Growth Rate (2015-2020)
6.6 Italy Antiviral Oral Liquid Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Antiviral Oral Liquid Revenue by Countries
7.1 Asia-Pacific Antiviral Oral Liquid Revenue by Countries (2015-2020)
7.2 China Antiviral Oral Liquid Revenue and Growth Rate (2015-2020)
7.3 Japan Antiviral Oral Liquid Revenue and Growth Rate (2015-2020)
7.4 Korea Antiviral Oral Liquid Revenue and Growth Rate (2015-2020)
7.5 India Antiviral Oral Liquid Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Antiviral Oral Liquid Revenue and Growth Rate (2015-2020)
8 South America Antiviral Oral Liquid Revenue by Countries
8.1 South America Antiviral Oral Liquid Revenue by Countries (2015-2020)
8.2 Brazil Antiviral Oral Liquid Revenue and Growth Rate (2015-2020)
8.3 Argentina Antiviral Oral Liquid Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Antiviral Oral Liquid by Countries
9.1 Middle East & Africa Antiviral Oral Liquid Revenue by Countries (2015-2020)
9.2 Saudi Arabia Antiviral Oral Liquid Revenue and Growth Rate (2015-2020)
9.3 UAE Antiviral Oral Liquid Revenue and Growth Rate (2015-2020)
9.4 Egypt Antiviral Oral Liquid Revenue and Growth Rate (2015-2020)
9.5 South Africa Antiviral Oral Liquid Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Antiviral Oral Liquid Revenue and Market Share by Type (2015-2020)
10.2 Global Antiviral Oral Liquid Market Forecast by Type (2019-2024)
10.3 Syrup Revenue Growth Rate (2015-2025)
10.4 Oral suspension Revenue Growth Rate (2015-2025)
10.5 Oral solution Revenue Growth Rate (2015-2025)
10.6 Oral drop Revenue Growth Rate (2015-2025)
10.7 Oral emulsion Revenue Growth Rate (2015-2025)
10.8 Mixture Revenue Growth Rate (2015-2025)
11 Global Antiviral Oral Liquid Market Segment by Application
11.1 Global Antiviral Oral Liquid Revenue Market Share by Application (2015-2020)
11.2 Antiviral Oral Liquid Market Forecast by Application (2019-2024)
11.3 Adults Revenue Growth (2015-2020)
11.4 Children Revenue Growth (2015-2020)
12 Global Antiviral Oral Liquid Market Size Forecast (2021-2025)
12.1 Global Antiviral Oral Liquid Market Size Forecast (2021-2025)
12.2 Global Antiviral Oral Liquid Market Forecast by Regions (2021-2025)
12.3 North America Antiviral Oral Liquid Revenue Market Forecast (2021-2025)
12.4 Europe Antiviral Oral Liquid Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Antiviral Oral Liquid Revenue Market Forecast (2021-2025)
12.6 South America Antiviral Oral Liquid Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Antiviral Oral Liquid Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Antiviral Oral Liquid Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Antiviral Oral Liquid by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Antiviral Oral Liquid Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Antiviral Oral Liquid Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Antiviral Oral Liquid Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Pfizer Corporate Information, Location and Competitors
Table 7. Pfizer Antiviral Oral Liquid Major Business
Table 8. Pfizer Antiviral Oral Liquid Total Revenue (USD Million) (2017-2018)
Table 9. Pfizer SWOT Analysis
Table 10. Pfizer Antiviral Oral Liquid Product and Solutions
Table 11. Pfizer Antiviral Oral Liquid Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Sanofi Corporate Information, Location and Competitors
Table 13. Sanofi Antiviral Oral Liquid Major Business
Table 14. Sanofi Antiviral Oral Liquid Total Revenue (USD Million) (2018-2019)
Table 15. Sanofi SWOT Analysis
Table 16. Sanofi Antiviral Oral Liquid Product and Solutions
Table 17. Sanofi Antiviral Oral Liquid Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Merck Corporate Information, Location and Competitors
Table 19. Merck Antiviral Oral Liquid Major Business
Table 20. Merck Antiviral Oral Liquid Total Revenue (USD Million) (2017-2018)
Table 21. Merck SWOT Analysis
Table 22. Merck Antiviral Oral Liquid Product and Solutions
Table 23. Merck Antiviral Oral Liquid Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Roche Corporate Information, Location and Competitors
Table 25. Roche Antiviral Oral Liquid Major Business
Table 26. Roche Antiviral Oral Liquid Total Revenue (USD Million) (2017-2018)
Table 27. Roche SWOT Analysis
Table 28. Roche Antiviral Oral Liquid Product and Solutions
Table 29. Roche Antiviral Oral Liquid Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. AbbVie Corporate Information, Location and Competitors
Table 31. AbbVie Antiviral Oral Liquid Major Business
Table 32. AbbVie Antiviral Oral Liquid Total Revenue (USD Million) (2017-2018)
Table 33. AbbVie SWOT Analysis
Table 34. AbbVie Antiviral Oral Liquid Product and Solutions
Table 35. AbbVie Antiviral Oral Liquid Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Novartis Corporate Information, Location and Competitors
Table 37. Novartis Antiviral Oral Liquid Major Business
Table 38. Novartis Antiviral Oral Liquid Total Revenue (USD Million) (2017-2018)
Table 39. Novartis SWOT Analysis
Table 40. Novartis Antiviral Oral Liquid Product and Solutions
Table 41. Novartis Antiviral Oral Liquid Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. AstraZeneca Corporate Information, Location and Competitors
Table 43. AstraZeneca Antiviral Oral Liquid Major Business
Table 44. AstraZeneca Antiviral Oral Liquid Total Revenue (USD Million) (2017-2018)
Table 45. AstraZeneca SWOT Analysis
Table 46. AstraZeneca Antiviral Oral Liquid Product and Solutions
Table 47. AstraZeneca Antiviral Oral Liquid Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Johnson & Johnson Corporate Information, Location and Competitors
Table 49. Johnson & Johnson Antiviral Oral Liquid Major Business
Table 50. Johnson & Johnson Antiviral Oral Liquid Total Revenue (USD Million) (2017-2018)
Table 51. Johnson & Johnson SWOT Analysis
Table 52. Johnson & Johnson Antiviral Oral Liquid Product and Solutions
Table 53. Johnson & Johnson Antiviral Oral Liquid Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. GlaxoSmithKline Corporate Information, Location and Competitors
Table 55. GlaxoSmithKline Antiviral Oral Liquid Major Business
Table 56. GlaxoSmithKline Antiviral Oral Liquid Total Revenue (USD Million) (2017-2018)
Table 57. GlaxoSmithKline SWOT Analysis
Table 58. GlaxoSmithKline Antiviral Oral Liquid Product and Solutions
Table 59. GlaxoSmithKline Antiviral Oral Liquid Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Bristol-Myers Squibb Corporate Information, Location and Competitors
Table 61. Bristol-Myers Squibb Antiviral Oral Liquid Major Business
Table 62. Bristol-Myers Squibb Antiviral Oral Liquid Total Revenue (USD Million) (2017-2018)
Table 63. Bristol-Myers Squibb SWOT Analysis
Table 64. Bristol-Myers Squibb Antiviral Oral Liquid Product and Solutions
Table 65. Bristol-Myers Squibb Antiviral Oral Liquid Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. CSL Corporate Information, Location and Competitors
Table 67. CSL Antiviral Oral Liquid Major Business
Table 68. CSL Antiviral Oral Liquid Total Revenue (USD Million) (2017-2018)
Table 69. CSL SWOT Analysis
Table 70. CSL Antiviral Oral Liquid Product and Solutions
Table 71. CSL Antiviral Oral Liquid Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Celgene Corporate Information, Location and Competitors
Table 73. Celgene Antiviral Oral Liquid Major Business
Table 74. Celgene Antiviral Oral Liquid Total Revenue (USD Million) (2017-2018)
Table 75. Celgene SWOT Analysis
Table 76. Celgene Antiviral Oral Liquid Product and Solutions
Table 77. Celgene Antiviral Oral Liquid Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Eli Lilly Corporate Information, Location and Competitors
Table 79. Eli Lilly Antiviral Oral Liquid Major Business
Table 80. Eli Lilly Antiviral Oral Liquid Total Revenue (USD Million) (2017-2018)
Table 81. Eli Lilly SWOT Analysis
Table 82. Eli Lilly Antiviral Oral Liquid Product and Solutions
Table 83. Eli Lilly Antiviral Oral Liquid Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. Allergan Corporate Information, Location and Competitors
Table 85. Allergan Antiviral Oral Liquid Major Business
Table 86. Allergan Antiviral Oral Liquid Total Revenue (USD Million) (2017-2018)
Table 87. Allergan SWOT Analysis
Table 88. Allergan Antiviral Oral Liquid Product and Solutions
Table 89. Allergan Antiviral Oral Liquid Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. Takeda Pharmaceuticals Corporate Information, Location and Competitors
Table 91. Takeda Pharmaceuticals Antiviral Oral Liquid Major Business
Table 92. Takeda Pharmaceuticals Antiviral Oral Liquid Total Revenue (USD Million) (2017-2018)
Table 93. Takeda Pharmaceuticals SWOT Analysis
Table 94. Takeda Pharmaceuticals Antiviral Oral Liquid Product and Solutions
Table 95. Takeda Pharmaceuticals Antiviral Oral Liquid Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 96. Gilead Sciences Corporate Information, Location and Competitors
Table 97. Gilead Sciences Antiviral Oral Liquid Major Business
Table 98. Gilead Sciences Antiviral Oral Liquid Total Revenue (USD Million) (2017-2018)
Table 99. Gilead Sciences SWOT Analysis
Table 100. Gilead Sciences Antiviral Oral Liquid Product and Solutions
Table 101. Gilead Sciences Antiviral Oral Liquid Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 102. Novo Nordisk Corporate Information, Location and Competitors
Table 103. Novo Nordisk Antiviral Oral Liquid Major Business
Table 104. Novo Nordisk Antiviral Oral Liquid Total Revenue (USD Million) (2017-2018)
Table 105. Novo Nordisk SWOT Analysis
Table 106. Novo Nordisk Antiviral Oral Liquid Product and Solutions
Table 107. Novo Nordisk Antiviral Oral Liquid Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 108. Merck KGaA Antiviral Oral Liquid Type and Application
Table 109. Merck KGaA Antiviral Oral Liquid Major Business
Table 110. Merck KGaA Antiviral Oral Liquid Total Revenue (USD Million) (2017-2018)
Table 111. Merck KGaA SWOT Analysis
Table 112. Merck KGaA Antiviral Oral Liquid Product and Solutions
Table 113. Merck KGaA Antiviral Oral Liquid Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 114. Bayer Corporate Information, Location and Competitors
Table 115. Bayer Antiviral Oral Liquid Major Business
Table 116. Bayer Antiviral Oral Liquid Total Revenue (USD Million) (2017-2018)
Table 117. Bayer SWOT Analysis
Table 118. Bayer Antiviral Oral Liquid Product and Solutions
Table 119. Bayer Antiviral Oral Liquid Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 120. Amgen Corporate Information, Location and Competitors
Table 121. Amgen Antiviral Oral Liquid Major Business
Table 122. Amgen Antiviral Oral Liquid Total Revenue (USD Million) (2017-2018)
Table 123. Amgen SWOT Analysis
Table 124. Amgen Antiviral Oral Liquid Product and Solutions
Table 125. Amgen Antiviral Oral Liquid Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 126. Global Antiviral Oral Liquid Revenue (Million USD) by Players (2015-2020)
Table 127. Global Antiviral Oral Liquid Revenue Share by Players (2015-2020)
Table 128. Global Antiviral Oral Liquid Revenue (Million USD) by Regions (2015-2020)
Table 129. Global Antiviral Oral Liquid Revenue Market Share by Regions (2015-2020)
Table 130. North America Antiviral Oral Liquid Revenue by Countries (2015-2020)
Table 131. North America Antiviral Oral Liquid Revenue Market Share by Countries (2015-2020)
Table 132. Europe Antiviral Oral Liquid Revenue (Million USD) by Countries (2015-2020)
Table 133. Asia-Pacific Antiviral Oral Liquid Revenue (Million USD) by Countries (2015-2020)
Table 134. South America Antiviral Oral Liquid Revenue by Countries (2015-2020)
Table 135. South America Antiviral Oral Liquid Revenue Market Share by Countries (2015-2020)
Table 136. Middle East and Africa Antiviral Oral Liquid Revenue (Million USD) by Countries (2015-2020)
Table 137. Middle East and Africa Antiviral Oral Liquid Revenue Market Share by Countries (2015-2020)
Table 138. Global Antiviral Oral Liquid Revenue (Million USD) by Type (2015-2020)
Table 139. Global Antiviral Oral Liquid Revenue Share by Type (2015-2020)
Table 140. Global Antiviral Oral Liquid Revenue Forecast by Type (2021-2025)
Table 141. Global Antiviral Oral Liquid Revenue by Application (2015-2020)
Table 142. Global Antiviral Oral Liquid Revenue Share by Application (2015-2020)
Table 143. Global Antiviral Oral Liquid Revenue Forecast by Application (2021-2025)
Table 144. Global Antiviral Oral Liquid Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Antiviral Oral Liquid Picture
Figure 2. Global Antiviral Oral Liquid Revenue Market Share by Type in 2019
Figure 3. Syrup Picture
Figure 4. Oral suspension Picture
Figure 5. Oral solution Picture
Figure 6. Oral drop Picture
Figure 7. Oral emulsion Picture
Figure 8. Mixture Picture
Figure 9. Antiviral Oral Liquid Revenue Market Share by Application in 2019
Figure 10. Adults Picture
Figure 11. Children Picture
Figure 12. Global Antiviral Oral Liquid Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Antiviral Oral Liquid Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Antiviral Oral Liquid Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Antiviral Oral Liquid Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Antiviral Oral Liquid Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Antiviral Oral Liquid Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Antiviral Oral Liquid Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Antiviral Oral Liquid Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Antiviral Oral Liquid Revenue Market Share in 2019
Figure 21. Global Top 10 Players Antiviral Oral Liquid Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Antiviral Oral Liquid Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Antiviral Oral Liquid Revenue Market Share by Regions (2015-2020)
Figure 25. Global Antiviral Oral Liquid Revenue Market Share by Regions in 2018
Figure 26. North America Antiviral Oral Liquid Revenue and Growth Rate (2015-2020)
Figure 27. Europe Antiviral Oral Liquid Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Antiviral Oral Liquid Revenue and Growth Rate (2015-2020)
Figure 29. South America Antiviral Oral Liquid Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Antiviral Oral Liquid Revenue and Growth Rate (2015-2020)
Figure 31. North America Antiviral Oral Liquid Revenue Market Share by Countries (2015-2020)
Figure 32. North America Antiviral Oral Liquid Revenue Market Share by Countries in 2019
Figure 33. USA Antiviral Oral Liquid Revenue and Growth Rate (2015-2020)
Figure 34. Canada Antiviral Oral Liquid Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Antiviral Oral Liquid Revenue and Growth Rate (2015-2020)
Figure 36. Europe Antiviral Oral Liquid Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Antiviral Oral Liquid Revenue Market Share by Countries in 2019
Figure 38. Germany Antiviral Oral Liquid Revenue and Growth Rate (2015-2020)
Figure 39. UK Antiviral Oral Liquid Revenue and Growth Rate (2015-2020)
Figure 40. France Antiviral Oral Liquid Revenue and Growth Rate (2015-2020)
Figure 41. Russia Antiviral Oral Liquid Revenue and Growth Rate (2015-2020)
Figure 42. Italy Antiviral Oral Liquid Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Antiviral Oral Liquid Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Antiviral Oral Liquid Revenue Market Share by Countries in 2019
Figure 45. China Antiviral Oral Liquid Revenue and Growth Rate (2015-2020)
Figure 46. Japan Antiviral Oral Liquid Revenue and Growth Rate (2015-2020)
Figure 47. Korea Antiviral Oral Liquid Revenue and Growth Rate (2015-2020)
Figure 48. India Antiviral Oral Liquid Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Antiviral Oral Liquid Revenue and Growth Rate (2015-2020)
Figure 50. South America Antiviral Oral Liquid Revenue Market Share by Countries (2015-2020)
Figure 51. South America Antiviral Oral Liquid Revenue Market Share by Countries in 2019
Figure 52. Brazil Antiviral Oral Liquid Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Antiviral Oral Liquid Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Antiviral Oral Liquid Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Antiviral Oral Liquid Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Antiviral Oral Liquid Revenue and Growth Rate (2015-2020)
Figure 57. UAE Antiviral Oral Liquid Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Antiviral Oral Liquid Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Antiviral Oral Liquid Revenue and Growth Rate (2015-2020)
Figure 60. Global Antiviral Oral Liquid Revenue Share by Type (2015-2020)
Figure 61. Global Antiviral Oral Liquid Revenue Share by Type in 2019
Figure 62. Global Antiviral Oral Liquid Market Share Forecast by Type (2021-2025)
Figure 63. Global Syrup Revenue Growth Rate (2015-2020)
Figure 64. Global Oral suspension Revenue Growth Rate (2015-2020)
Figure 65. Global Oral solution Revenue Growth Rate (2015-2020)
Figure 66. Global Oral drop Revenue Growth Rate (2015-2020)
Figure 67. Global Oral emulsion Revenue Growth Rate (2015-2020)
Figure 68. Global Mixture Revenue Growth Rate (2015-2020)
Figure 69. Global Antiviral Oral Liquid Revenue Share by Application (2015-2020)
Figure 70. Global Antiviral Oral Liquid Revenue Share by Application in 2019
Figure 71. Global Antiviral Oral Liquid Market Share Forecast by Application (2021-2025)
Figure 72. Global Adults Revenue Growth Rate (2015-2020)
Figure 73. Global Children Revenue Growth Rate (2015-2020)
Figure 74. Global Antiviral Oral Liquid Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Antiviral Oral Liquid Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Antiviral Oral Liquid Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Antiviral Oral Liquid Revenue Market Forecast (2021-2025)
Figure 78. Europe Antiviral Oral Liquid Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Antiviral Oral Liquid Revenue Market Forecast (2021-2025)
Figure 80. South America Antiviral Oral Liquid Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Antiviral Oral Liquid Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
双黄連経口液の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Shuanghuanglian Oral Liquid market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…- 経口X線装置の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Oral X-Ray Machines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Oral X-Ray Machines marke…
- 口腔がん迅速検査キットの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Oral Cancer Rapid Test Kit market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Oral Cancer Rapid …
- 経口抗糖尿病（OAD）治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Oral Antidiabetic (OAD) Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Oral Antidi…
- 経口抗凝固薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Oral Anticoagulants market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.8% in the forecast period of 2020 to 2025 and will expected to reach USD 19430 million by 2025, from USD 14950 million in 2019. The Oral Anticoagulant…